News & Events
CPRIT Appoints Tracey B. Davies As Chief Strategic Initiatives and Intellectual Property Officer
The Cancer Prevention and Research Institute of Texas (CPRIT) announced today the appointment of Tracey B. Davies as Chief Strategic Initiatives and Intellectual Property Officer.
Cancer Prevention & Research Institute of Texas Awards $12 Million in New Recruitment Grants
The Cancer Prevention and Research Institute of Texas (CPRIT) today awarded two new academic research grants totaling $12 million to recruit eminent cancer researchers to Texas.
Cancer Prevention & Research Institute of Texas Awards $26 Million in New Recruitment Grants
The Cancer Prevention and Research Institute of Texas (CPRIT) today awarded nine new academic research grants totaling $26 million to recruit cancer researchers to Texas.
CPRIT Statement on the Selection of Zhijian "James" Chen, PhD for the William B. Coley Award
The Cancer Prevention and Research Institute of Texas (CPRIT) congratulates Zhijian "James" Chen, Ph.D., for receiving the prestigious 2020 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology from the Cancer Research Institute.
2020 Healthier Texas Summit Series Running Now Through October
The Healthier Texas Summit is a collaboration between It's Time Texas and The University of Texas System that brings together thought leaders and health champions from all sectors to advance a shared vision: transforming health in Texas. As the only conference of its kind bringing together cross-sector thought leaders and local health champions to unite for a healthier Texas, the Summit will be offered as a free, digital series in 2020.
TMC ACT presents "Small Business Funding Opportunities from the National Cancer Institute"
On August 11, 2020 at 1:00 pm CST, Team Leader Greg Evans and Program Directors Christie Canaria and Nancy Kamei of the National Cancer Institute Small Business Innovation Research Development Center (NCI SBIR) will provide funding, networking, and mentoring assistance to small businesses with early-stage innovative cancer technology projects.